project id: TCGA-BRCA; case submitter id: TCGA-AN-A04C; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.9; rna integrity number: 7.4; spectrophotometer method: UV Spec; age at index: 51; days to birth: -18851; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1957; age at diagnosis: 18851; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 54.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 656; initial weight: 190.0; sample id: 4a7e95e4-58b5-4e96-a029-98f294b3cd54; sample submitter id: TCGA-AN-A04C-01A; portion id: 114061e5-c3f6-4aaa-94b4-fa750a4d305b; portion submitter id: TCGA-AN-A04C-01A-21; percent neutrophil infiltration: 0.0; percent normal cells: 0.0;